CP-222 Clinical experience of panitumumab monotherapy as treatment for metastatic colorectal cancer

• Published in: European journal of hospital pharmacy. Science and practice Vol. 24; no. Suppl 1; pp. A99 - A100
• Main Authors: Gasque, MP Monforte, García, I Hernández, Elizondo, M Castresana, Llorens, M Elviro, Valencia, M Gutiérrez, Fabo, E Lacalle, Lizarraga, R Astiz, Hernando, E Pellejero, Basarte, J Alfaro
• Format: Journal Article
• Language: English
• Published: London BMJ Publishing Group LTD 01.03.2017
• Subjects: Colorectal cancer; Metastasis; Monoclonal antibodies; Targeted cancer therapy

BackgroundPanitumumab is a fully human monoclonal antibody Ig G2 whose target is the epidermal growth factor receptor (EGFR). It is indicated as monotherapy to treat patients with metastatic colorectal cancer (mCRC) that show EGFR with wild-type KRAS, after failure of chemotherapy regimens containin...